Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06672510 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE)
A NA study of Pulmonary Embolism Acute, sponsored by Akura Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 118
- Enrollment target
- 12
- Study locations
NCT06672510 is a NA study of Pulmonary Embolism Acute that is actively recruiting participants, run by Akura Medical. The registered enrollment target is 118 participants. The trial reports 12 study locations across 9 states.
The verdict
NCT06672510, a NA study of Pulmonary Embolism Acute, is actively recruiting participants, sponsored by Akura Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
- 12
- Study locations
Study Summary
This study is a prospective, single-arm, interventional, multicenter study to evaluate the safety and effectiveness of percutaneous mechanical thrombectomy using the Akura Thrombectomy System in subjects with acute pulmonary embolism (PE).
Conditions Studied
Interventions
- DEVICE ATC
Study Locations (12)
Florida
- Manatee Hospital / Nova Clinical Research Center - Bradenton
- Jacksonville Memorial (HCA) - Jacksonville
- Tallahasse Memorial Hospital - Tallahassee
New York
- Columbia University Medical Center - New York
- Cumc/Nyph - New York
California
- Los Robles Regional Medical Center - Thousand Oaks
Colorado
- Advanced Heart & Vein (ClinRe-001-001) - Thornton
Connecticut
- Hartford Healthcare - Hartford
Minnesota
- Centracare Heart & Vascular Center - Saint Cloud
Ohio
- ProMedica Toledo Hospital - Toledo
Tennessee
- Tristar Centennial Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06672510
The ClinicalTrials.gov registry entry for NCT06672510 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akura Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Embolism Acute appearing as the primary indexed condition, and to 1 intervention - of which ATC is the first listed.
NCT06672510 reports 12 study locations spanning 9 distinct geographic areas - top geographies include Florida, New York, California.
Frequently Asked Questions
What is clinical trial NCT06672510 about?
NCT06672510 is a clinical study titled "Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE)". This study is a prospective, single-arm, interventional, multicenter study to evaluate the safety and effectiveness of percutaneous mechanical thrombectomy using the Akura Thrombectomy System in subjects with acute pulmonary embolism (PE).
What is the current status of trial NCT06672510?
This trial is currently recruiting. It is a NA study. The enrollment target is 118 participants. The study started on 2025-01-01. Estimated completion is 2026-12.
What conditions does trial NCT06672510 study?
This clinical trial studies the following conditions: Pulmonary Embolism Acute.
What interventions are being tested in trial NCT06672510?
The interventions under investigation include: ATC (DEVICE).
Who is sponsoring clinical trial NCT06672510?
This trial is sponsored by Akura Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06672510 being conducted?
This trial has 12 study locations across California, Colorado, Connecticut, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.